Synthetic biology square-off

This weekend, 59 teams of undergraduates will be descending on Cambridge, Mass., for the 4th annual International Genetically Engineered Machines competition, aka the linkurl:iGEM Jamoboree.;http://parts.mit.edu/r/parts/igem/index.cgi I'm heading up there tomorrow to blog the event live. The event is a synthetic biology contest that grew out of a short course held at MIT in 2003. Students - mostly undergrads - spend the summer designing and building genetic machines from a standard set of biolo

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
This weekend, 59 teams of undergraduates will be descending on Cambridge, Mass., for the 4th annual International Genetically Engineered Machines competition, aka the linkurl:iGEM Jamoboree.;http://parts.mit.edu/r/parts/igem/index.cgi I'm heading up there tomorrow to blog the event live. The event is a synthetic biology contest that grew out of a short course held at MIT in 2003. Students - mostly undergrads - spend the summer designing and building genetic machines from a standard set of biological parts called "biobricks." Last year's winners, from the University of Ljubljana in Slovenia, engineered cells that fight sepsis. This year, the Ljubljana team is back, with a synthetic antiviral defense system against HIV. Check in this weekend for updates as the judges poke and prod that project and others, such as learning-enabled E. coli and microbes with metabolisms tweaked to produce biofuels.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio